$86.11
0.530.62%
In chiusura: -
$86.19
0.080.09%
Pre-mercato: 7:26 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Edwards Lifesciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
feb 10
Stima EPS
$0.610
Stima dei ricavi trimestrali
$1.54B
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$5.88B
Analizza lo storico degli utili di Edwards Lifesciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
EW | Edwards Lifesciences | $0.59 | $0.61 | — | — | $1.39B | $1.54B | — | — | 02/10/2026 | |
EW | Edwards Lifesciences | $0.67 | $0.59 | $0.67 | 13.56% | $1.35B | $1.50B | $1.55B | 3.66% | 10/30/2025 | |
EW | Edwards Lifesciences | $0.70 | $0.62 | $0.67 | 8.06% | $1.63B | $1.49B | $1.53B | 3.01% | 07/24/2025 | |
EW | Edwards Lifesciences | $0.66 | $0.60 | $0.64 | 6.67% | $1.60B | $1.40B | $1.41B | 0.71% | 04/23/2025 | |
EW | Edwards Lifesciences | $0.64 | $0.55 | $0.59 | 7.27% | $1.53B | $1.36B | $1.39B | 1.91% | 02/11/2025 | |
EW | Edwards Lifesciences | $0.55 | $0.64 | $0.67 | 4.69% | $1.24B | $1.52B | $1.35B | -10.92% | 10/24/2024 | |
EW | Edwards Lifesciences | $0.66 | $0.69 | $0.70 | 1.45% | $1.53B | $1.65B | $1.63B | -1.09% | 07/24/2024 | |
EW | Edwards Lifesciences | $0.62 | $0.64 | $0.66 | 3.12% | $1.46B | $1.57B | $1.60B | 1.78% | 04/25/2024 | |
EW | Edwards Lifesciences | $0.64 | $0.64 | $0.64 | 0.00% | $1.35B | $1.49B | $1.53B | 2.95% | 02/06/2024 | |
EW | Edwards Lifesciences | $0.61 | $0.59 | $0.59 | 0.00% | $1.32B | $1.48B | $1.48B | 0.07% | 10/25/2023 | |
EW | Edwards Lifesciences | $0.63 | $0.65 | $0.66 | 1.54% | $1.37B | $1.50B | $1.53B | 2.00% | 07/26/2023 | |
EW | Edwards Lifesciences | $0.60 | $0.61 | $0.62 | 1.64% | $1.34B | $1.39B | $1.46B | 5.04% | 04/26/2023 | |
EW | Edwards Lifesciences | $0.51 | $0.61 | $0.64 | 4.92% | $1.33B | $1.33B | $1.35B | 1.35% | 01/31/2023 | |
EW | Edwards Lifesciences | $0.54 | $0.62 | $0.61 | -1.61% | $1.31B | $1.33B | $1.32B | -0.83% | 10/27/2022 | |
EW | Edwards Lifesciences | $0.64 | $0.64 | $0.63 | -1.56% | $1.38B | $1.40B | $1.37B | -1.86% | 07/28/2022 | |
EW | Edwards Lifesciences | $0.54 | $0.57 | $0.60 | 5.26% | $1.22B | $1.31B | $1.34B | 2.37% | 04/26/2022 | |
EW | Edwards Lifesciences | $0.50 | $0.55 | $0.51 | -7.27% | $1.19B | $1.36B | $1.33B | -2.21% | 01/26/2022 | |
EW | Edwards Lifesciences | $0.51 | $0.53 | $0.54 | 1.89% | $1.14B | $1.32B | $1.31B | -0.76% | 10/27/2021 | |
EW | Edwards Lifesciences | $0.34 | $0.55 | $0.64 | 16.36% | $925.00M | $1.28B | $1.38B | 7.50% | 07/29/2021 | |
EW | Edwards Lifesciences | $0.50 | $0.47 | $0.54 | 14.89% | $1.13B | $1.16B | $1.22B | 4.91% | 04/20/2021 | |
EW | Edwards Lifesciences | $0.49 | $0.53 | $0.50 | -5.66% | $1.17B | $1.19B | $1.19B | 0.17% | 01/27/2021 |
Edwards Lifesciences (EW) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $0.67 | $0.59 | 13.6 % |
| Q2 | 2025-07-24 | $0.67 | $0.62 | 8.06 % |
| Q1 | 2025-04-23 | $0.64 | $0.60 | 6.67 % |
| Q4 | 2025-02-11 | $0.59 | $0.55 | 7.27 % |
Edwards Lifesciences (EW) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $1.55B | $1.50B | 3.66 % |
| Q2 | 2025-07-24 | $1.53B | $1.49B | 3.01 % |
| Q1 | 2025-04-23 | $1.41B | $1.40B | 0.71 % |
| Q4 | 2025-02-11 | $1.39B | $1.36B | 1.91 % |
FAQ
Quando Edwards Lifesciences (NYSE:EW) riporterà gli utili?
Si prevede che Edwards Lifesciences (EW) fornisca risultati il febbraio 10, 2026. Gli ultimi risultati sono stati pubblicati il ottobre 30, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Edwards Lifesciences (NYSE:EW)?
L'EPS effettivo era $0.67, che superato la stima di $0.59.
Quali sono state le entrate di Edwards Lifesciences (NYSE:EW)?
Le entrate effettive sono state $1.6B, che superato la stima di $1.5B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.